Evidence map›Paper›PMID 35387065›Full record

ReviewFrontiers in allergy2021

Allergic Rhinitis in Childhood and the New EUFOREA Algorithm.

Glenis Kathleen Scadding, Peter Kenneth Smith, Michael Blaiss, Graham Roberts, Peter William Hellings, Philippe Gevaert, Marinda Mc Donald, Tania Sih, Suzanne Halken, Petra Ursula Zieglmayer and 4 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in allergy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Machine learning-derived asthma and allergy trajectories in children: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2025
    Pooled it
  2. Trial
  3. Review
  4. Predicting the course of chronic rhinosinusitis in young children-5-year prospective study.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Twenty-five years: The fexofenadine clinical experience.The World Allergy Organization journal · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 13 institutions in 12 countries.

Glenis Kathleen ScaddingEar, Nose and Throat Department, University College London Hospitals National Health Service Foundation Trust, London, United Kingdom.
Peter Kenneth SmithAllergy Medical Group, Brisbane, QLD, Australia.
Michael BlaissDepartment of Paediatrics, Medical College of Georgia, Augusta University, Augusta, GA, United States.
Graham RobertsNational Institute of Health Research Biomedical Research Centre, Southampton General Hospital, Southampton, United Kingdom.
Peter William HellingsDepartment of Microbiology and Immunology, Department of Otorhinolaryngology, Katholieke Universiteit Leuven, Leuven, Belgium.
Philippe GevaertDepartment of Otorhinolaryngology, Ghent University, Ghent, Belgium.
Marinda Mc DonaldThe Allergy Clinic, Johannesburg, South Africa.
Tania SihMedical School, University of São Paulo, São Paulo, Brazil.
Suzanne HalkenPaediatric Allergy, University of Southern Denmark, Odense, Denmark.
Petra Ursula ZieglmayerKarl Landsteiner University of Health Sciences, Krems an der Donau, Austria.
Peter Schmid-GrendelmeierAllergy Unit, Dermatology Department, University Hospital of Zurich, Eidgenössische Technische Hochschule Zürich, Zurich, Switzerland.
Erkka ValovirtaDepartment of Lung Diseases and Clinical Immunology, University of Turku and Terveystalo Allergy Clinic, Turku, Finland.
Ruby PawankarDivision of Allergy, Department of Pediatrics, Nippon Medical School, Tokyo, Japan.
Ulrich WahnKlinik für Pädiatrie m.S. Pneumologie und Immunologie, Charite-Berlin, Berlin, Germany.
Augusta University · USCharité - Universitätsmedizin Berlin · DEDavid Hide Asthma and Allergy Research Centre · GBETH Zurich · CHGhent University Hospital · BEJohannesburg Hospital · ZAKU Leuven · BENational Health Service · GBNippon Medical School · JPUniversidade de São Paulo · BRUniversity of Southern Denmark · DKUniversity of Turku · FIVienna Challenge Chamber · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allergic rhinitis in childhood has been often missed, mistreated and misunderstood. It has significant comorbidities, adverse effects upon quality of life and educational performance and can progress to asthma or worsen control of existing asthma. Accurate diagnosis and effective treatment are important. The new EUFOREA algorithm provides a succinct but wide- ranging guide to management at all levels, based on previous guidelines with updated evidence and has been adjusted and approved by experts worldwide.

Indexed as

allergen specific immunotherapyantihistaminesasthmafixed dose combinationsintranasal corticosteroidspediatric allergic rhinitissleep

Identifiers

PMID35387065
PMCPMC8974858
OpenAlexW3181598262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.